Mayo Symposium with BioFlorida – December 11th, 2016

On behalf of Mayo Clinic, we invite you to join us for a special presentation on the Mayo Clinic campus in beautiful Jacksonville, Florida. Spend the afternoon hearing from innovative leaders with Mayo Clinic’s Center for Individualized Medicine and Center for Regenerative Medicine, as they share how we integrate the latest technology and research breakthroughs into the clinical practice to personalize care for patients. Afterward, enjoy a tour of the Mayo Clinic J. Wayne and Delores Barr Weaver Simulation Center, where you will explore how Mayo teams apply our renowned collaborative practice model and advance education across specialties for practitioners within Mayo Clinic and beyond.

Fees and Information

Your ticket to the Mayo Symposium includes:

-Transportation from the Hyatt Regency Jacksonville Riverfront to the Mayo Clinic at 12:30 PM

- Hear from speakers with Mayo Clinic’s Center for Individualized Medicine and Center for Regenerative Medicine

-Refreshments

-Tour of the Mayo Clinic J. Wayne and Delores Barr Weaver Simulation Center

-Transportation from the Mayo Clinic to the Hyatt Regency Jacksonville Riverfront at 3:45 PM

Pricing:
BioFlorida Member: $40.00

Non-Member: $50.00
Registration Closes December 5th, 2016

Location

Mayo Clinic

Davis Building: Walker Auditorium

4500 San Pablo Road

Jacksonville, FL 32224

Agenda 

Moderator

Charles J. Bruce, MD

Professor of Medicine

Mayo Clinic College of Medicine

Department of Cardiovascular Diseases

Biography:

Charles Bruce, M.D., serves as the Associate Medical Director for Mayo Clinic Ventures, as well as Director for Business Development in the Center for Regenerative Medicine at Mayo Clinic in Florida.  He is a practicing cardiologist as well as a researcher, inventor, and professor of Medicine. His unique perspective into the challenges of health care delivery are shaped by his medical experiences in South Africa and the United States. Dr. Bruce is an accomplished innovator who helped create five start-up companies. He holds more than 20 issued patents for medical inventions.

Shane A. Shapiro, MD

Instructor in Family Medicine

Assistant Professor of Orthopedics

Mayo Clinic College of Medicine

Biography:

Regenerative medicine is a game-changing area of medicine with the potential to fully heal damaged tissues and organs, offering solutions and hope for people who have conditions that today are beyond repair. Dr. Shane Shapiro, Assistant Professor of Orthopedic Surgery at Mayo Clinic College of Medicine, studies novel regenerative techniques for chronic non-healing bone, joint, muscle, tendon, ligament and skin maladies that are not candidates for conventional surgical management. Dr. Shapiro has research protocols involving both bone marrow and adipose derived stem cells to treat arthritis, and recently, completed an FDA IND clinical trial using mesenchymal stem cells to treat osteoarthritic knees.

George Vasmatzis, PhD

Director of Biomarker Discovery Program  

Mayo Clinic Center for Individualized Medicine 

Biography:

Dr. George Vasmatzis is the director of the Biomarker Discovery Program, within the Center for Individualized Medicine, and his research program consists of bioinformatics specialists, molecular biologists, epidemiologists, and pathologists. He is a Consultant in the Department of Molecular Medicine and a member of the Mayo Clinic Cancer Center. He is also an Assistant Professor in the Department of Laboratory Medicine at the Mayo Medical School.  He has a Ph.D. in Biomedical Engineering and has acquired experience in diverse disciplines, including Bioinformatics, Molecular Biology, and Computational Biology.  His laboratory has demonstrated success in discovery and translation of several biomarkers as well as developing evidence-based models that should help clinicians stratify (cancer) patients in order to provide each individual with the appropriate care.  With the recent advances in Next Generation Sequencing (NGS) technologies the laboratory have been engaging in massive sequencing to scan the genome of cancer cells for abnormalities that can be used for clinical purposes such as diagnosis and stratification of patients for optimal treatment.  Published papers in Journal of Clinical Oncology, Cancer Research and BLOOD further demonstrate their discovery, validation and translation capabilities.

John D. Fryer, PhD

Associate Professor of Neuroscience

Mayo Clinic College of Medicine

Assistant Dean Mayo Graduate School in Florida

Biography:

The laboratory of John D. Fryer, Ph.D., studies the pathogenesis of Alzheimer's disease, focusing on molecular mechanisms of known genetic risk factors. Dr. Fryer also dedicates his time to researching the role of the gut microbiome in mental health. The microbes in the gut and their collective genomes (the microbiome) have an increasingly recognized role in human health and disease. Dr. Fryer's team found that a high-fat diet and exercise both dramatically alter the levels of these microbes and associated levels of anxiety and cognition. The lab is now pursuing investigations of how the gut microbiome can be manipulated to alter mood and cognition in both mouse models and human populations.